Literature DB >> 12888109

Current concepts in psoriasis and its treatment.

C O Mendonça1, A D Burden.   

Abstract

Many advances have been made in our understanding of the biology of psoriasis over the past 20 years. We are close to knowing the genetic determinants of psoriasis. There is now greater insight into the immunological mechanisms that produce the phenotype, and the possibility of intervening selectively to antagonise some of these mechanisms is becoming a reality. Nevertheless, psoriasis remains an enigmatic disease, and much of the suffering it produces is not adequately addressed. The sheer number of treatments that are used therapeutically suggests a lack of efficacy and/or toxicity of many of these approaches. In this review, we aim to briefly describe the biology of psoriasis, document the key features of treatments that are available or under development, and explain how these treatments can be used effectively to manage this chronic relapsing disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888109     DOI: 10.1016/s0163-7258(03)00041-x

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  5 in total

Review 1.  Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?

Authors:  Neil H Shear
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  A case of psoriasis pustolosa palmaris induced by cetuximab.

Authors:  Elena Marinello; Davide Pastorelli; Mauro Alaibac
Journal:  BMJ Case Rep       Date:  2016-03-18

3.  Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial.

Authors:  Tiffani Hamilton; Alan Menter; Ivor Caro; Peter Compton; Jeffrey Sobell; Kim A Papp
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 4.  Promiscuous drugs compared to selective drugs (promiscuity can be a virtue).

Authors:  Simon K Mencher; Long G Wang
Journal:  BMC Clin Pharmacol       Date:  2005-04-26

5.  Liposomal and Ethosomal Gels for the Topical Delivery of Anthralin: Preparation, Comparative Evaluation and Clinical Assessment in Psoriatic Patients.

Authors:  Dina Fathalla; Eman M K Youssef; Ghareb M Soliman
Journal:  Pharmaceutics       Date:  2020-05-11       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.